Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia

被引：1
|
作者：
Wu, Qian
He, Guangsheng
Wu Depei
Sun, Aining
Qiu, Huiying
Jin, Zhengming
Miao, Miao
Tang, XiaoWen
Han, Yue
Shen, Yiming
Chen, Feng
Hu, Xiaohui
Jin, Song
Zhang, Xuhui
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5031.5031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5031
引用
收藏
页数：1
相关论文
共 50 条
  • [31] DECITABINE COMBINED WITH HAAG REGIMEN IS AN EFFECTIVE SALVAGE TREATMENT FOR ADVANCED ACUTE MYELOID LEUKEMIA
    Cui, W.
    Jin, Z.
    Sun, A.
    Qiu, H.
    Miao, M.
    Cao, J.
    Guo, D.
    Wu, D.
    Tang, X.
    HAEMATOLOGICA, 2017, 102 : 382 - 382
  • [32] Decitabine Combined with Haag Regimen Is an Effective Salvage Treatment for Advanced Acute Myeloid Leukemia
    Tang, XiaoWen
    Cui, Wei
    Jin, Zhengming
    Zhu, Xiaming
    Sun, Aining
    Qiu, Huiying
    Miao, Miao
    Cao, Jing
    Guo, Dandan
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [33] Venetoclax plus hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia Two case reports
    Wang, Hongxia
    Bai, Junjun
    Pei, Zhixin
    Zhang, Bei
    Wang, Junjie
    Lian, Xingli
    Song, Qinglin
    MEDICINE, 2020, 99 (47) : E23265
  • [34] FLAG-IDA: A HIGHLY EFFECTIVE SALVAGE REGIMEN IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA
    Virijevic, M.
    Suvajdzic-Vukovic, N.
    Djunic, I.
    Novkovic, A.
    Mitrovic, M.
    Colovic, N.
    Vidovic, A.
    Tomin, D.
    HAEMATOLOGICA, 2013, 98 : 520 - 520
  • [35] Decitabine Combined with Low-Dose Chemotherapy Is Effective in the Treatment of Pediatric Refractory/Relapsed Acute Myeloid Leukemia
    Fan, Liyan
    Jiang, Hua
    Liu, Hongjun
    Liao, Ning
    Wang, Ningling
    Zhai, Xiaowen
    Ju, Xiuli
    Liu, Yufeng
    Luo, Jixia
    Xiao, Peifang
    Lu, Jun
    He, Hailong
    Wang, Yi
    Ribeiro, Raul C.
    Hu, Shaoyan
    BLOOD, 2023, 142
  • [36] Efficacy and safety evaluation of Venetoclax combined with homoharringtonine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia
    Wei, Mingxia
    Shen, Xuliang
    Zhai, Chunyan
    Gao, Wenyu
    PANMINERVA MEDICA, 2024,
  • [37] Clinical outcomes in patients with relapsed/refractory acute leukemia treated with FLAG-IDA regimen.
    Basquiera, Ana L.
    Prates, M. Virginia
    Sturich, Ana Gabriela
    Berretta, Adriana R.
    Milone, Jorge
    Garcia, Juan
    BLOOD, 2006, 108 (11) : 220B - 220B
  • [38] FLAG-ida as a stem cell mobilization regimen in patients with primary refractory or relapsed acute leukemia
    Cagirgan, S
    Pehlivan, M
    Donmez, A
    Talu, P
    Yilmaz, M
    Tombuloglu, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S257
  • [39] High dose cytarabine and cyclophosphamide (hAC) regimen for relapsed or refractory acute myeloid leukemia (AML): a retrospective monocentric analysis
    Fix, P.
    Fricke, H-J
    Spies-Weisshart, B.
    La Rosee, P.
    Hochhaus, A.
    Scholl, S.
    ONKOLOGIE, 2010, 33 : 138 - 139
  • [40] Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia
    Tolosa-Ridao, Carles
    Suarez-Lledo, Maria
    Jimenez-Vicente, Carlos
    Cortes-Bullich, Albert
    Merchan, Beatriz
    Martinez-Roca, Alexandra
    Guijarro, Francisca
    Castano-Diez, Sandra
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Diaz-Beya, Marina
    Esteve, Jordi
    Rovira, Montserrat
    Salas, Maria Queralt
    BONE MARROW TRANSPLANTATION, 2024, 59 (08) : 1199 - 1201
12345